Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients
Isaac Rosado‐Sánchez(Instituto de Biomedicina de Sevilla), Anna Rull(Institut de Recerca Biomèdica Catalunya Sud), Yolanda M. Pacheco(Instituto de Biomedicina de Sevilla), Pol Herrero(Centre for Omic Sciences), Manuel Leal(Apple (Israel)), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Francisco Fanjul(Hospital Universitario Son Espases), Enrique Bernal(Honeywell (United States)), Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Julià Blanco(IrsiCaixa), Miguel López-Dupla, Sergi Veloso, Ricardo Pelazas(Hospital Universitario de Canarias), Esther Rodríguez‐Gallego(Institut de Recerca Biomèdica Catalunya Sud), Joaquim Peraire(Instituto de Salud Carlos III), Félix Gutiérrez(Universitat de Miguel Hernández d'Elx)
Cited by 25
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Ultraviolet vision in lizards
|Nature|1993|257
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
|International Journal of Infectious Diseases|2020|226